STIM Financials: Neuronetics Inc AI Analysis

Home

Stock

STIM

Financials

STIM Financial

Neuronetics Inc

$1.48

-7.18%

$-0.11

As of today:Mar 24, 14:55:29 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$1.6

Open

$1.59

Day's Range

$1.44 - $1.59

52 week range

$0.8 - $5.05

Volume

532.0K

Avg.Volume

1.9M

Dividend yield

EPS (TTM)

-0.83

Market Cap

$101.7M

What is STIM?

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 716 full-time employees. The company went IPO on 2018-06-28. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The firm provides more than 7.1 million treatments to over 1,95,000 patients.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

STIM Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	129	74	71	65	55	49
Revenue Growth (YoY)	79%	4%	9%	18%	12%	-21%
Cost of Revenue	64	20	19	15	11	11
Gross Profit	65	54	51	49	43	37
Selling, General & Admin	92	75	72	75	63	50
Research & Development	6	8	9	9	7	9
Operating Expenses	103	84	82	84	71	60
Other Non Operating Income (Expenses)	1	2	5	1	0	0
Pretax Income	-44	-43	-30	-37	-31	-27
Income Tax Expense	--	--	--	--	--	--
Net Income	-44	-43	-30	-37	-31	-27
Net Income Growth	22%	43%	-19%	19%	15%	-7%
Shares Outstanding (Diluted)	67.3	31.73	28.65	26.9	25.48	18.84
Shares Change (YoY)	122%	11%	7%	6%	35%	3%
EPS (Diluted)	-0.66	-1.37	-1.05	-1.38	-1.22	-1.46
EPS Growth	-46%	31%	-24%	13%	-16%	-8%
Free Cash Flow	-30	-32	-34	-34	-30	-29
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	50.38%	72.97%	71.83%	75.38%	78.18%	75.51%
Operating Margin	-28.68%	-40.54%	-42.25%	-53.84%	-49.09%	-44.89%
Profit Margin	-34.1%	-58.1%	-42.25%	-56.92%	-56.36%	-55.1%
Free Cash Flow Margin	-23.25%	-43.24%	-47.88%	-52.3%	-54.54%	-59.18%
EBITDA	-34	-28	-28	-34	-26	-22
EBITDA Margin	-26.35%	-37.83%	-39.43%	-52.3%	-47.27%	-44.89%
D&A For EBITDA	3	2	2	1	1	0
EBIT	-37	-30	-30	-35	-27	-22
EBIT Margin	-28.68%	-40.54%	-42.25%	-53.84%	-49.09%	-44.89%
Effective Tax Rate	--	--	--	--	--	--

Follow-Up Questions

What are Neuronetics Inc's key financial statements?



According to the latest financial statement (Form-10K), Neuronetics Inc has a total asset of $140, Net loss of $-43

What are the key financial ratios for STIM?



Neuronetics Inc's Current ratio is 1.23, has a Net margin is -58.1, sales per share of $2.33.

How is Neuronetics Inc's revenue broken down by segment or geography?



Neuronetics Inc largest revenue segment is Treatment Sessions, at a revenue of 51,650,000 in the most earnings release.For geography, United States is the primary market for Neuronetics Inc, at a revenue of 69,336,000.

Is Neuronetics Inc profitable?



no, according to the latest financial statements, Neuronetics Inc has a net loss of $-43

Does Neuronetics Inc have any liabilities?



yes, Neuronetics Inc has liability of 113

How many outstanding shares for Neuronetics Inc?



Neuronetics Inc has a total outstanding shares of 55.67

Neuronetics Inc (STIM) Financial

STIM Stock Price Chart